Grown Rogue International (GRUSF) Current Leases (2017 - 2026)
Grown Rogue International's (GRUSF) quarterly Current Leases came in at $965115.0 in Q1 2026, up 14.14% year-on-year from $845563.0 in Q1 2025, and up 14.29% quarter-over-quarter from $844421.0 in Q4 2025.
Grown Rogue International (GRUSF) Current Leases (2017 - 2026) Analysis & Trends
Grown Rogue International's Current Leases history runs 10 years deep, the most recent figure standing at $965115.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 14.14% year-over-year to $965115.0 in Q1 2026; TTM through Mar 2026 was $965115.0, a 14.14% increase from a year earlier, with the FY2025 full-year figure at $844421.0, down 19.41% from the prior year.
- Current Leases advanced to $965115.0 in Q1 2026 per GRUSF's latest filing, from $844421.0 in the prior quarter.
- Across five years, Current Leases topped out at $950.9 billion in Q3 2025 and bottomed at $526942.2 in Q3 2024.
- The 5-year median for Current Leases is $903254.0 (2025), against an average of $67.9 billion.
- Across the five-year window, Current Leases retreated 19.61% in 2023 and surged 180452691.91% in 2025, its largest moves.
- Year by year, Current Leases stood at $1.0 million in 2022, then slumped by 33.67% to $680162.3 in 2023, then jumped by 54.05% to $1.0 million in 2024, then fell by 19.41% to $844421.0 in 2025, then climbed by 14.29% to $965115.0 in 2026.
- Per Business Quant, the three latest GRUSF Current Leases figures stand at $965115.0 (Q1 2026), $844421.0 (Q4 2025), and $950.9 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 965,115.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 965,115.00 |
| Dec 31, 2025 | 844,421.00 |
| Sep 30, 2025 | 950.88 Bn |
| Jun 30, 2025 | 960,945.00 |
| Mar 31, 2025 | 845,563.00 |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 526,942.25 |
| Jun 30, 2024 | 529,888.26 |
| Mar 31, 2024 | 741,086.00 |
| Dec 31, 2023 | 680,162.27 |
| Oct 31, 2023 | 824,271.00 |
| Apr 30, 2023 | 1.04 Mn |
| Jan 31, 2023 | 1.28 Mn |
| Oct 31, 2022 | 1.03 Mn |
| Oct 31, 2021 | 624,935.00 |
| Apr 30, 2021 | 273,525.00 |
| Jan 31, 2021 | 175,662.00 |
| Oct 31, 2020 | 100,277.00 |
| Jul 31, 2020 | 97,808.00 |
| Apr 30, 2020 | 162,154.00 |